- Exchange: NASDAQ GM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Ligand Pharmaceuticals Inc+ Add to Watchlist
LGND:US79.8000 USD 2.1600 2.78%
As of 20:10:00 ET on 05/01/2015.
Company Profile for Ligand Pharmaceuticals Inc (LGND)
Ligand Pharmaceuticals Incorporated develops drugs which regulate hormone activated intracellular receptors. These receptors play a role in regulating the genetic processes affecting diseases such as gynecological disorders, certain cancers, as well as cardiovascular, inflammatory, and skin diseases.
Ligand Pharmaceuticals Inc
Key Executives for Ligand Pharmaceuticals Inc (LGND)
|John L HigginsChief Executive Officer||Matthew W Foehr "Matt"President/COO|
|Melanie J HermanChief Accounting Officer||Charles S BerkmanVP/Secretary/General Counsel|
|Nishan De SilvaVP:Finance & Strategy/CFO||Erika Luib-De La CruzInvestor Relations|